$heff's $tation of $tocks & $olid DD

[pmony5]

$7's breaking out ADMP tiny Biotech co. 9.9 mill shares out & float of 7.3 Mill shares..spent 50 mins on phone with management Fri & here are some facts.. 65 million $$$ market Cap for any biotech is very cheap but for a pipeline like ADMP's is insanely cheap. Biggest news imo is Tier 1 giant 95 Billion dollar 3M is their partner on newly purchased inhaler asset developed over 10 years by 3M. 3M retains all manufacturing rights & inhaler rights outside of drug sector. ADMP can license the inhaler to other drug co.s & pursue their own drugs. First objective is Glaxo's Advair which ADMP will file a 505b & make a generic Advair product. Currently Glaxo is all alone even though Advair came off patent 3 years ago as Advair uses a dual drug & others have found it extremely difficult to produce including TEVA who gave up. Advair enjoys worldwide sales over 8 bill $$$ & over 6 Billion in the U.S. alone. In Sept the FDA lowered guidelines to try & advance a generic Advair product so FDA wants competition in the market a huge plus... also the drug data by Glaxo will be used by ADMP so time to market will be much shorter then starting from scratch. When asked I was told between manufacturing compliance 6 to 8 months & phase 3 trials which will consist of 12 weeks but of course FDA paperwork, trial composition, enrollment and data results seems like 2nd quarter 2015 ADMP will submit NDA & early 2016 hitting the market. I know that seems a long time away but remember entering a 6 billion dollar U.S. market & sure to capture imo a large % due to much lower prices but even conservative 20 to 25% would be well over 1 Billion in sales. What valuation would a co. doing those types of sales value at in the market ? ADMP is at 65 Million dollar market cap. I would say they are cheap if this were the ONLY product they have BUT wait lets look at pipeline.

Epinepherine aka Epi pen s/b approved late 2014 as NDA filing in 1st Qtr

APC-1000 HFA branded generic inhaled oral steroid for asthma Phase 3 Trials 2.7 Bill $$$ Market

APC-3000 for Allergic Rhintis HFA Generic inhaled Nasal Steroid Phase 3 Trial 4 Bill $$$ market

APC 100 & 200 Prostate drugs currently in Phase 1 & obtained from University of Wisconsin.

TeloB-Vax an Immune based therapy in Phase 2 & basically it works by telling the bodies own immune system to create custom T-cells & kills up to 85% of all cancers. Better description here

http://www.adamispharmaceuticals.com/products-telob-vax.php

C31G a spermicide that according to co. is looking for partner for final leg & FDA submission.

CASH & DEBT ... Always a concern for me on Bio's is cash, cash burn & future dilution well take a look at recent financing done by ADMP. I was told they had Multiple deals on the table once 3M product was secured & a very nice deal indeed... First thing that jumped out at me was NO Warrants in deal a clean financing done. Over allotment s/b a done deal & leaves ADMP with approx 11+ Mill $$$$ & that's after paying off 3M & Convertible Note Holders of some 7.2 million... The only dilution out there is some 800K warrants from June priced at $5.95 a share so would land ADMP another 4.9 mill in Cash if exercised. That's it CLEAN & NO debt. Management also feels license deals may develop in 2014 adding cash to the balance sheet as well & was told worse case no warrant dollars & no license deal they s/b fine cash wise to the end of 2014 early 2015.

Well some other links to further DD & listing great 3M data on newly acquired inhaler..

http://seekingalpha.com/article/1868881-adamis-pharmaceuticals-two-companies-for-the-price-of-one?source=yahoo

http://solutions.3m.com/3MContentRetrievalAPI/BlobServlet?lmd=1314037544000&locale=en_WW&assetType=MMM_Image&assetId=1273684149733&blobAttribute=ImageFile

http://solutions.3m.com/3MContentRetrievalAPI/BlobServlet?lmd=1314026034000&locale=en_WW&assetType=MMM_Image&assetId=1273685196267&blobAttribute=ImageFile

http://solutions.3m.com/3MContentRetrievalAPI/BlobServlet?lmd=1314027541000&locale=en_WW&assetType=MMM_Image&assetId=1273684150144&blobAttribute=ImageFile

http://solutions.3m.com/3MContentRetrievalAPI/BlobServlet?lmd=1316792825000&locale=en_WW&assetType=MMM_Image&assetId=1273695579274&blobAttribute=ImageFile

Last but not least FDA lowers guidelines for Generic Advair huge plus for ADMP going forward

http://www.ft.com/cms/s/0/33dd6cd6-1a2f-11e3-b3da-00144feab7de.html#axzz2pSXapSG7